Insulet
The world leader of automated diabetes management
Image credit - © Insulet Corporation. All rights reserved.
What does it do?
Insulet Corporation was founded in 2000 by a father and entrepreneur who was dissatisfied with the existing insulin delivery options for his young son. He knew there had to be a better way, so he got to work. What began as a sketch on a napkin, is today a trailblazer in the healthcare space, revolutionising diabetes management with its Omnipod Insulin Management System.
The Omnipod 5, their flagship product, is the first and only FDA-cleared automated insulin delivery system for both type 1 and type 2 diabetes in the U.S. A person living with insulin-dependent diabetes makes approximately 300 decisions per day to manage their care. But using propriety technology, this tubeless, wearable device provides continuous insulin delivery for up to three days, eliminating the need for constant decision making, multiple daily injections, or finger prick testing.
Why do we invest?
Insulet's commitment to innovation and global expansion positions it as a leader in the diabetes care industry, with a presence in 25 countries. Its market leadership is secured by numerous patents and the engineering complexities of its devices, paired with the Omnipod 5 being first and only automated insulin delivery system in the U.S. for both type 1 and type 2 diabetes.
Insulet has demonstrated robust financial performance, with consistent revenue growth driven by the increasing adoption of its Omnipod systems. There is also significant runway for continued international growth as the company remains dedicated to advancing diabetes management and improving patient outcomes worldwide.
All these factors combined, plus the company’s disruptive nature, make Insulet a compelling growth opportunity and a promising addition to the Scottish Mortgage portfolio.
Who is key?
The passion of Insulet’s founder to revolutionise diabetes management lives on in the vision of the company. Insulet is now led by President and Chief Executive Officer Jim Hollingshead, Ph.D.
When
Founded in: 2000
Invested in: 2024
Where
Headquartered: U.S.
Important information
The company showcased on this page is part of a diversified portfolio. The commentary should not be taken as advice on an individual stock.
Investment trusts are UK public companies and are not authorised and regulated by the Financial Conduct Authority. You may not get back the amount invested and please bear in mind that past performance is not a guide to future performance.